You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 2, February 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Osteogenic Sarcoma of the Jaw

A Clinicopathologic Review of 12 Patients

Moshe Lewis, MD; Alexander Perl, MD; Peter M. Som, MD; Mark L. Urken, MD; Margaret S. Brandwein, MD

Arch Otolaryngol Head Neck Surg. 1997;123(2):169-174.


Abstract

Objective
To review our experience with osteogenic sarcoma of the jaw.

Data Source
The pathology and clinical files of the Mount Sinai Medical Center, New York, NY, were examined.

Study Selection
For the past 6 years, 12 pathologically documented cases were identified.

Data Extraction
Surgical resection margins, histological tumor grade and subtype, and treatment modality were reexamined with regard to effect on outcome.

Data Synthesis
The mean age of occurrence was 32.6 years, ranging from 12 to 60 years. Male predominance was noted in both mandibular and maxillary tumors. Local recurrence occurred in 6 of 12 patients after 3 months to 5 years; 4 of these patients have either persistant disease or died of disease. In this recurrence group, only 2 patients remain disease free 7 and 12 years after initial diagnosis and 6.5 and 8 years after recurrence.

Conclusions
This study is too small to draw statistically significant conclusions. However, the longest survivor in the group (disease free at 12 years) had a histologically low-grade mandibular tumor. We reiterate the findings in the literature, which agree that osteogenic sarcoma of the jaw is an aggressive disease. Patient prognosis may depend on the tumor grade and size on presentation, as well as the completeness of initial surgery as monitored by resection margins.

Arch Otolaryngol Head Neck Surg. 1997;123:169-174



Author Affiliations

From the School of Medicine (Drs Lewis and Perl), Departments of Pathology (Dr Brandwein), Otolaryngology (Drs Brandwein and Urken), and Radiology (Dr Som), Mount Sinai School of Medicine, City University of New York, New York, NY.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Quiz Case 1
Sorensen et al.
Arch Otolaryngol Head Neck Surg 2000;126:550-552.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.